1d
Zacks.com on MSNJBL Boosts Healthcare Portfolio With Strategic Buyout: Stock to Gain?Jabil, Inc. JBL recently announced that it has completed the acquisition of Pharmaceutics International, Inc. for an ...
1d
Zacks.com on MSNJabil (JBL) Surpasses Market Returns: Some Facts Worth KnowingJabil (JBL) closed the most recent trading day at $163.62, moving +1.11% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.39%. Meanwhile, the Dow experienced a rise ...
SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...
Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to ...
A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.
Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...
Jabil's (NYSE:JBL) investors will be pleased with their incredible 333% return over the last five years ...
In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...
Global manufacturer Jabil plans to hire hundreds of new workers at a Northern Kentucky facility. STORY HIGHLIGHTS Jabil plans ...
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results